ME Therapeutics Inc.
$203,000.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2017-2018
- Agreement period
- September 1, 2017 – March 31, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q2-892718
Published purpose
A monoclonal antibody to block tumor-associated immunosuppression by altering immune cell development will be developed in preparation for preclinical development and clinical trials.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions